These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 26815291

  • 1. Thrombolysis with Low-Dose Tissue Plasminogen Activator 3-4.5 h After Acute Ischemic Stroke in Five Hospital Groups in Japan.
    Morihara R, Kono S, Sato K, Hishikawa N, Ohta Y, Yamashita T, Deguchi K, Manabe Y, Takao Y, Kashihara K, Inoue S, Kiriyama H, Abe K.
    Transl Stroke Res; 2016 Apr; 7(2):111-9. PubMed ID: 26815291
    [Abstract] [Full Text] [Related]

  • 2. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S, Deguchi K, Morimoto N, Kurata T, Deguchi S, Yamashita T, Ikeda Y, Matsuura T, Narai H, Omori N, Manabe Y, Yunoki T, Takao Y, Kawata S, Kashihara K, Abe K.
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [Abstract] [Full Text] [Related]

  • 3. Intravenous thrombolysis with neuroprotective therapy by edaravone for ischemic stroke patients older than 80 years of age.
    Kono S, Deguchi K, Morimoto N, Kurata T, Yamashita T, Ikeda Y, Narai H, Manabe Y, Takao Y, Kawada S, Kashihara K, Takehisa Y, Inoue S, Kiriyama H, Abe K.
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1175-83. PubMed ID: 23507462
    [Abstract] [Full Text] [Related]

  • 4. YAMATO Study (Tissue-Type Plasminogen Activator and Edaravone Combination Therapy).
    Aoki J, Kimura K, Morita N, Harada M, Metoki N, Tateishi Y, Todo K, Yamagami H, Hayashi K, Terasawa Y, Fujita K, Yamamoto N, Deguchi I, Tanahashi N, Inoue T, Iwanaga T, Kaneko N, Mitsumura H, Iguchi Y, Ueno Y, Kuramoto Y, Ogata T, Fujimoto S, Yokoyama M, Nagahiro S, YAMATO Study Investigators.
    Stroke; 2017 Mar; 48(3):712-719. PubMed ID: 28119434
    [Abstract] [Full Text] [Related]

  • 5. Edaravone with and without .6 Mg/Kg Alteplase within 4.5 Hours after Ischemic Stroke: A Prospective Cohort Study (PROTECT4.5).
    Yamaguchi T, Awano H, Matsuda H, Tanahashi N, PROTECT4.5 Investigators.
    J Stroke Cerebrovasc Dis; 2017 Apr; 26(4):756-765. PubMed ID: 27887792
    [Abstract] [Full Text] [Related]

  • 6. A new therapeutic strategy for acute ischemic stroke: sequential combined intravenous tPA-tenecteplase for proximal middle cerebral artery occlusion based on first results in 13 consecutive patients.
    Smadja D, Chausson N, Joux J, Saint-Vil M, Signaté A, Edimonana M, Jeannin S, Bartoli B, Aveillan M, Cabre P, Olindo S.
    Stroke; 2011 Jun; 42(6):1644-7. PubMed ID: 21527758
    [Abstract] [Full Text] [Related]

  • 7. Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke onset.
    Mathews MS, Sharma J, Snyder KV, Natarajan SK, Siddiqui AH, Hopkins LN, Levy EI.
    Neurosurgery; 2009 Nov; 65(5):860-5; discussion 865. PubMed ID: 19834397
    [Abstract] [Full Text] [Related]

  • 8. Solitaire™ with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial: protocol for a randomized, controlled, multicenter study comparing the Solitaire revascularization device with IV tPA with IV tPA alone in acute ischemic stroke.
    Saver JL, Goyal M, Bonafe A, Diener HC, Levy EI, Pereira VM, Albers GW, Cognard C, Cohen DJ, Hacke W, Jansen O, Jovin TG, Mattle HP, Nogueira RG, Siddiqui AH, Yavagal DR, Devlin TG, Lopes DK, Reddy V, du Mesnil de Rochemont R, Jahan R, SWIFT PRIME Investigators.
    Int J Stroke; 2015 Apr; 10(3):439-48. PubMed ID: 25777831
    [Abstract] [Full Text] [Related]

  • 9. Relationship between magnetic resonance angiography-diffusion-weighted imaging mismatch and clinical outcome in endovascular treatment for acute ischemic stroke: subgroup analysis of the Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism--Japan Registry.
    Deguchi I, Dembo T, Yoshimura S, Sakai N, Okada Y, Kitagawa K, Kimura K, Hyogo T, Yamagami H, Egashira Y, Tanahashi N.
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1471-6. PubMed ID: 24685994
    [Abstract] [Full Text] [Related]

  • 10. Reperfusion after 4.5 hours reduces infarct growth and improves clinical outcomes.
    Picanço MR, Christensen S, Campbell BC, Churilov L, Parsons MW, Desmond PM, Barber PA, Levi CR, Bladin CF, Donnan GA, Davis SM, EPITHET Investigators.
    Int J Stroke; 2014 Apr; 9(3):266-9. PubMed ID: 24256139
    [Abstract] [Full Text] [Related]

  • 11. Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke.
    Kruetzelmann A, Köhrmann M, Sobesky J, Cheng B, Rosenkranz M, Röther J, Schellinger PD, Ringleb P, Gerloff C, Fiehler J, Thomalla G.
    Stroke; 2011 May; 42(5):1251-4. PubMed ID: 21415399
    [Abstract] [Full Text] [Related]

  • 12. Current status of intravenous thrombolysis for acute ischemic stroke in Asia.
    Sharma VK, Ng KW, Venketasubramanian N, Saqqur M, Teoh HL, Kaul S, Srivastava PM, Sergentanis T, Suwanwela N, Nguyen TH, Lawrence Wong KS, Chan BP.
    Int J Stroke; 2011 Dec; 6(6):523-30. PubMed ID: 22111797
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Intravenous thrombolysis for acute ischemic stroke in the 3- to 4·5-hour window--the Malabar experience.
    Salam KA, Ummer K, Pradeep Kumar VG, Noone ML.
    Int J Stroke; 2014 Jun; 9(4):426-8. PubMed ID: 23981667
    [Abstract] [Full Text] [Related]

  • 15. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study.
    Albers GW, Bates VE, Clark WM, Bell R, Verro P, Hamilton SA.
    JAMA; 2000 Mar 01; 283(9):1145-50. PubMed ID: 10703776
    [Abstract] [Full Text] [Related]

  • 16. The correlation between admission blood glucose and intravenous rt-PA-induced arterial recanalization in acute ischemic stroke: a multi-centre TCD study.
    Saqqur M, Shuaib A, Alexandrov AV, Sebastian J, Khan K, Uchino K.
    Int J Stroke; 2015 Oct 01; 10(7):1087-92. PubMed ID: 26332252
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Standard-dose intravenous tissue-type plasminogen activator for stroke is better than low doses.
    Liao X, Wang Y, Pan Y, Wang C, Zhao X, Wang DZ, Wang C, Liu L, Wang Y, Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China Investigators.
    Stroke; 2014 Aug 01; 45(8):2354-8. PubMed ID: 25013020
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Rescue localized intra-arterial thrombolysis for hyperacute MCA ischemic stroke patients after early non-responsive intravenous tissue plasminogen activator therapy.
    Kim DJ, Kim DI, Kim SH, Lee KY, Heo JH, Han SW.
    Neuroradiology; 2005 Aug 01; 47(8):616-21. PubMed ID: 15983773
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.